Last reviewed · How we verify
HMPL-A580
At a glance
| Generic name | HMPL-A580 |
|---|---|
| Sponsor | Hutchmed |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HMPL-A580 CI brief — competitive landscape report
- HMPL-A580 updates RSS · CI watch RSS
- Hutchmed portfolio CI